Advancing the Cholangiocarcinoma & Myeloid Lymphoid Neoplasm Patient Journey

 

Scripps MD Anderson Cancer Center
B

What’s New: Oncology Drug Updates - Part 2

By Scripps MD Anderson Cancer Center FEATURING Bryan Do
By Scripps MD Anderson Cancer Center FEATURING Bryan Do
70 views
November 10, 2023
0 Comments
Login to view comments. Click here to Login
Advancing the Cholangiocarcinoma & Myeloid Lymphoid Neoplasm Patient Journey
13:45
Flavio Rocha

How to Incorporate Molecular Testing in Therapy for Localized Cholan…

06:22
Milind Javle

Importance of Molecular Profiling in Biliary Tract Cancer

30:00
2023 Johns Hopkins Updates in Gastrointestinal Cancers

Managing Treatment-Related Side Effects in GI Cancers: Chemo, Target…

Feat. P. Griffith
03:51
Moffitt Cancer Center

Real-World Characteristics, Treatment Patterns, and Outcomes of Pati…

Feat. R. Kim
04:16
Moffitt Cancer Center

Real-World Use of Pemigatinib for Cholangiocarcinoma Among Racial an…

Feat. R. Kim
08:24
ASH 2022 Conference Coverage

Phase 2 FIGHT-203 Study: Pemigatinib in Pts With Myeloid/Lymphoid Ne…

Feat. A. Vannucchi
16:57
Scripps MD Anderson Cancer Center

What’s New: Oncology Drug Updates - Part 2

Feat. B. Do
16:40
Moffitt Cancer Center

Year in Review: Hepatobiliary Cancers

Feat. R. Kim, T. Biachi
14:33
Insights from 2023 ESMO Annual Meeting

Personalized Medicine and Targeted Agents for Biliary Tract Cancer

Feat. L. Rimassa
21:46
Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "Past, Present & Future Clinical M…

Feat. M. Ikeda